市場調查報告書
商品編碼
1468358
泌尿科機器人手術市場報告按組件(機器人手術系統、儀器和配件、服務)、應用(機器人前列腺切除術、機器人膀胱切除術、機器人腎盂成形術、機器人腎切除術等)和地區2024-2032Urology Robotic Surgery Market Report by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2024-2032 |
IMARC Group年,全球泌尿機器人手術市場規模達18億美元。骨退化性疾病和腎臟或泌尿道疾病的盛行率不斷增加,特別是在老年人群中,以及對膝關節和髖關節置換術的微創輔助手術的需求不斷成長,是推動市場的一些關鍵因素。
泌尿科機器人手術是一種微創治療,包括微型電腦控制的機械手和帶有攝影機和人工感測解決方案的手術器械。這些設備在醫療保健專業人員的監督下,透過各種機器人控制台放置在小穿孔中,而不是大切口中,以到達遠處和關鍵的空間,並查看待手術區域的高度放大且清晰的3D( 3D) 圖片。它包括機器人、導航系統、模擬器、規劃器和其他關鍵配件作為標準設備類型。泌尿外科機器人手術可提供精確的運動和更高的放大倍率,最大限度地提高生產力,確保治療過程中的同儕協作,並最大限度地減少恢復時間、失血量和術後併發症。除此之外,它還可以減少疤痕、疼痛、不適和感染風險,確保縮短住院時間並提供更好的臨床結果。因此,泌尿科機器人手術在醫院和診所廣泛用於前列腺切除術、膀胱切除術、腎切除術和腎盂成形術手術。
腎臟或泌尿道疾病盛行率的增加是推動市場成長的關鍵因素之一。容易患此類疾病的老年人口的增加也促進了市場的成長。與此一致的是,由於膝關節和髖關節置換術的微創輔助手術相對於傳統手術具有多種優勢,因此對膝關節和髖關節置換術的微創輔助手術的需求不斷成長,這是另一個促進成長的因素。此外,對可顯著減少人為錯誤機會的自動化手術工具的需求不斷成長,正在推動市場成長。此外,機器人輔助軟性內視鏡與系統的整合使醫療保健從業者能夠存取和治療複雜的解剖結構並提高診斷過程的精度,這有利於市場成長。此外,軟體執行的遠端運動中心(RCM)和具有複雜運動控制功能的模組化機器人手術系統的出現正在推動市場成長。除此之外,正在進行的研發(R&D)活動旨在製造具有更高功效的泌尿外科手術機器人,並促進手術干預產品的多樣化,正在為市場創造積極的前景。其他因素,例如增加醫療保健預算和改善醫療保健基礎設施,正在推動市場成長。
The global urology robotic surgery market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032. The increasing prevalence of bone degenerative and kidney or urinary tract diseases, especially amongst the geriatric population, along with the rising demand for minimally invasive assisted surgeries for knee and hip replacements, represent some of the key factors driving the market.
Urology robotic surgery is a minimally invasive treatment that includes miniaturized computer-controlled manipulators and surgical instruments with a video camera and artificial sensing solutions. These devices are placed in small punctures instead of large incisions by various robotic consoles under the supervision of healthcare professionals to reach distant and critical spaces and view highly magnified and clear three-dimensional (3D) pictures of the area to be operated. It encompasses robotic machines, navigation systems, simulators, planners, and other crucial accessories as standard equipment types. Urology robotic surgery offers accurate motions and increased magnification, maximizes productivity, ensures peer collaborations during treatment procedures, and minimizes recovery time, blood loss, and post-surgical complications. Apart from this, it reduces scarring, pain, discomfort, and the risk of infection ensures shorter hospitalization and provides better clinical outcomes. As a result, urology robotic surgeries are extensively utilized in hospitals and clinics for prostatectomy, cystectomy, nephrectomy, and pyeloplasty surgical procedures.
The increasing prevalence of kidney or urinary tract diseases represents one of the key factors driving the market growth. The increasing geriatric population, which is susceptible to such ailments, is also contributing to the market growth. In line with this, the rising demand for minimally invasive assisted surgeries for knee and hip replacements, due to their multiple benefits over traditional surgical procedures, is acting as another growth-inducing factor. Additionally, the rising need for automated surgical tools that significantly reduce the chances of human errors is driving the market toward growth. Moreover, the integration of robot-assisted flexible endoscopes with the system that enables healthcare practitioners to access and treat complex anatomies and enhance precision in diagnostic proceedings is favoring the market growth. Furthermore, the advent of the software-enforced remote center of motion (RCM) and modular robotic surgical systems with complex motion control capability is impelling the market growth. Apart from this, the ongoing research and development (R&D) activities to manufacture urology surgical robots with enhanced efficacy and the fueling number of product diversification for surgical interventions are creating a positive outlook for the market. Other factors, such as increasing healthcare budgets and improving healthcare infrastructure, are driving the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global urology robotic surgery market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on component and application.
Robotic Surgery Systems
Instruments and Accessories
Services
The report has also provided a detailed breakup and analysis of urology robotic surgery market based on the component. This includes robotic surgery systems, instruments and accessories and services. According to the report, instruments and accessories represented the largest segment.
Robotic Prostatectomy
Robotic Cystectomy
Robotic Pyeloplasty
Robotic Nephrectomy
Others
A detailed breakup and analysis of the urology robotic surgery market based on the application has also been provided in the report. This includes robotic prostatectomy, robotic cystectomy, robotic pyeloplasty, robotic nephrectomy and others. According to the report, robotic prostatectomy accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for urology robotic surgery. Some of the factors driving the North America urology robotic surgery market included the increasing prevalence of kidney and urinary tract diseases and the rising geriatric population.
The report has also provided a comprehensive analysis of the competitive landscape in the global urology robotic surgery market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Intuitive Surgical Inc., Johnson & Johnson, Medtronic plc, Stryker Corporation, Surgical Science Sweden AB, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.